BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2006
View Archived Issues
Istradefylline shows potential in restless legs syndrome
Read More
XP-13512 improves restless legs syndrome symptoms in polysomnography trial
Read More
Transgene and NCI sign melanoma CRADA letter of intent
Read More
Enrollment completed in study of DAC:GRF for HIV-associated lipodystrophy
Read More
Affibody and GE Healthcare enter research agreement
Read More
PharmaGap seeks to outlicense or sell PhG-alpha1
Read More
Positive findings in European study of Repel-CV
Read More
Corgentech changes name to Anesiva
Read More
Enrollment open in phase IIa study of NCX-1000 in portal hypertension
Read More
Phase I study of CR011-vcMMAE for melanoma commences
Read More
Preclinical findings for Mymetics' HIV-AIDS prophylactic vaccine candidate
Read More
Desonate NDA accepted for filing
Read More
Compound Therapeutics changes name to Adnexus Therapeutics
Read More
Bone loss treatment ACE-011 enters phase I
Read More
Clearance for phase I/II trial protocol of AMZ-0026 in HIV patients
Read More
Phase I study cleared to begin for CT-322 in cancer
Read More
DG-041 begins phase II program for peripheral artery disease
Read More
AA-4500 highly effective in treatment of Dupuytren's contracture
Read More
bPiDDB blocks nicotine-induced dopamine release in the nucleus accumbens
Read More
Novel human anticocaine monoclonal antibody limits cocaine distribution to the brain
Read More
FDA approval for extended- and immediate-release oxymorphone hydrochloride
Read More
Accelerated approval for Prezista in HIV combination therapy
Read More
Lumigan approved for first-line use
Read More
Recent patents describe novel therapeutic agents for atopic dermatitis, psoriasis
Read More
Novel treatments for inflammatory disorders claimed in recent patents
Read More
Recent patents disclose new therapeutic agents for psychological disorders
Read More
Fenofibrate/metformin combination effective in patients with metabolic syndrome
Read More
Extract from Artemisia dracunculus shows promising antidiabetic properties
Read More
Favorable pharmacokinetic profile of apricitabine in healthy subjects
Read More
Novel topoisomerase II inhibitor shows potent antitumor activity in vivo
Read More